Ambev S.A. (LON:0A6X)
2.440
+0.039 (1.61%)
At close: Nov 7, 2025
Ambev Revenue
Ambev had revenue of 20.85B BRL in the quarter ending September 30, 2025, a decrease of -5.65%. This brings the company's revenue in the last twelve months to 90.47B, up 9.79% year-over-year. In the year 2024, Ambev had annual revenue of 89.45B with 12.18% growth.
Revenue (ttm)
90.47B BRL
Revenue Growth
+9.79%
P/S Ratio
2.30
Revenue / Employee
2.10M BRL
Employees
43,000
Market Cap
29.07B GBP
Revenue Chart
* This company reports financials in BRL.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 89.45B | 9.72B | 12.18% |
| Dec 31, 2023 | 79.74B | 28.03M | 0.04% |
| Dec 31, 2022 | 79.71B | 6.85B | 9.41% |
| Dec 31, 2021 | 72.85B | 14.48B | 24.80% |
| Dec 31, 2020 | 58.38B | 6.37B | 12.26% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| HSBC Holdings | 43.13B |
| AstraZeneca | 41.24B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |